Search results for "Diabetic Retinopathy"

showing 10 items of 134 documents

INTRAVITREAL BEVACIZUMAB FOR PROLIFERATIVE DIABETIC RETINOPATHY

2017

PURPOSE To evaluate the effects of intravitreal bevacizumab (IVB) on retinal neovascularization in patients with proliferative diabetic retinopathy (PDR). METHODS Retrospective multicenter interventional case series. A chart review was performed of 81 consecutive patients (97 eyes) with retinal neovascularization due to PDR, who received at least 1 IVB injection. RESULTS The mean age of the patients was 55.6 ± 11.6 years. The mean number of IVB injections was 4 ± 2.5 injections (range, 1-8 injections) per eye. The mean interval between IVB applications was 3 ± 7 months. The mean duration of follow-up was 29.6 ± 2 months (range, 24-30 months). Best-corrected visual acuity and optical coheren…

0301 basic medicinemedicine.medical_specialtyVisual acuitygenetic structuresBevacizumabmedicine.medical_treatmentVitrectomy03 medical and health sciences0302 clinical medicineOphthalmologymedicineAdverse effectRetinabusiness.industryRetrospective cohort studyGeneral MedicineDiabetic retinopathymedicine.diseaseeye diseasesOphthalmology030104 developmental biologymedicine.anatomical_structureVitreous hemorrhage030221 ophthalmology & optometrysense organsmedicine.symptombusinessmedicine.drugRetina
researchProduct

Pterostilbene Prevents Early Diabetic Retinopathy Alterations in a Rabbit Experimental Model

2019

Oxidative stress generated by diabetes plays a key role in the development of diabetic retinopathy (DR), a common diabetic complication. DR remains asymptomatic until it reaches advanced stages, which complicate its treatment. Although it is known that good metabolic control is essential for preventing DR, knowledge of the disease is incomplete and an effective treatment with no side effects is lacking. Pterostilbene (Pter), a natural stilbene with good antioxidant activity, has proved to beneficially affect different pathologies, including diabetes. Therefore, our study aimed to analyse the protective and/or therapeutic capacity of Pter against oxidant damage by characterising early retina…

Male0301 basic medicinepterostilbenePterostilbeneretinal damageNF-E2-Related Factor 2lcsh:TX341-641Pharmacologymedicine.disease_causeAntioxidantsArticlePhosphatidylinositol 3-Kinases03 medical and health scienceschemistry.chemical_compound0302 clinical medicineDiabetes mellitusStilbenesmedicineAnimalsoxidative stressProtein kinase BPI3K/AKT/mTOR pathwayType 1 diabetesGlycogen Synthase Kinase 3 betaNutrition and Dieteticsbusiness.industryDiabetic retinopathymedicine.diseaseEnzyme ActivationDisease Models Animaldiabetic retinopathypolyphenol030104 developmental biologychemistryHyperglycemia030220 oncology & carcinogenesisMetabolic control analysisRabbitsbusinesslcsh:Nutrition. Foods and food supplyProto-Oncogene Proteins c-aktOxidative stressSignal TransductionFood ScienceNutrients
researchProduct

Evidence for a dysfunction and disease-promoting role of the circadian clock in the diabetic retina.

2021

Diabetic retinopathy is a major complication of chronic hyperglycemia and a leading cause of blindness in developed countries. In the present study the interaction between diabetes and retinal clocks was investigated in mice. It was seen that in the db/db mouse - a widely used animal model of diabetic retinopathy - clock function and circadian regulation of gene expression was disturbed in the retina. Remarkably, elimination of clock function by Bmal1-deficiency mitigates the progression of pathophysiology of the diabetic retina. Thus high-fat diet was seen to induce histopathology and molecular markers associated with diabetic retinopathy in wild type but not in Bmal1-deficient mice. The d…

Blood GlucoseMalemedicine.medical_specialtyCircadian clockCLOCK ProteinsDiseaseChronobiology DisordersPathogenesisCellular and Molecular Neurosciencechemistry.chemical_compoundMiceDiabetes mellitusInternal medicineCircadian ClocksRNA Ribosomal 18SMedicineAnimalsRNA MessengerRetinaDiabetic Retinopathybusiness.industryGlyceraldehyde-3-Phosphate DehydrogenasesRetinalDiabetic retinopathymedicine.diseaseSensory SystemsPathophysiologyCircadian RhythmMice Inbred C57BLOphthalmologyDisease Models Animalmedicine.anatomical_structureEndocrinologychemistryMicroscopy FluorescenceFemalebusinessExperimental eye research
researchProduct

Automated fundus images analysis techniques to screen retinal diseases in diabetic patients

2011

In this Ph.D. thesis, we study new methods to analyse digital fundus images of diabetic patients. In particular, we concentrate on the development of the algorithmic components of an automatic screening system for diabetic retinopathy. The techniques developed can be categorized in: quality assessment and improvement, lesion segmentation and diagnosis. For the first category, we present a fast algorithm to numerically estimate the quality of a single image by employing vasculature and colour-based features; additionally, we show how it is possible to increase the image quality and remove reflection artefacts by merging information gathered in multiple fundus images (which are captured by ch…

Fundus image analysisOedème maculaire[INFO.INFO-OH] Computer Science [cs]/Other [cs.OH]Macular edemaRétinopathie diabétique[SDV.MHEP] Life Sciences [q-bio]/Human health and pathologyAnalyse du fond d'oeilDiabetic retinopathy[ SDV.MHEP ] Life Sciences [q-bio]/Human health and pathology[INFO.INFO-OH]Computer Science [cs]/Other [cs.OH][ INFO.INFO-OH ] Computer Science [cs]/Other [cs.OH][SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
researchProduct

Polyunsaturated fatty acids and Plasmalogens in diabetics

2012

Purpose Plasmalogens (PLS) are phospholipids characterized by a vinyl ether bond and a preferential esterification of polyunsaturated fatty acids (PUFA). We have previously shown that the lack of PLS leads to retinal hyper-capillarization. We hypothesize that PLS are negative regulators of vascular development, and aimed to check their circulating levels in diabetic patients. Methods Blood samples were collected from 88 patients and 14 control subjects. Among diabetics we had 14 patients without diabetic retinopathy (DR), 12 with a mild non proliferative DR, 12 with a moderate non proliferative DR, 22 with a severe non proliferative DR and 24 with a proliferative DR (PDR). Erythrocytes were…

chemistry.chemical_classificationmedicine.medical_specialtyChemistryRetinalGeneral MedicineDiabetic retinopathymedicine.diseasePathogenesisOphthalmologychemistry.chemical_compoundEndocrinologyBiochemistryDocosahexaenoic acidInternal medicineTriple quadrupole mass spectrometrymedicinelipids (amino acids peptides and proteins)Arachidonic acidGas chromatographyPolyunsaturated fatty acidActa Ophthalmologica
researchProduct

Predictors of microvascular complications in type 1 diabetic patients at onset: The role of metabolic memory

2011

Background Several epidemiological studies showed a close association between metabolic control and microvascular complications in type 1 Diabetes Mellitus (T1DM). The aim of our longitudinal observational study was to evaluate the predictive role of the main clinical and biochemical parameters in determining microvascular complications. Methods 376 T1DM patients, hospitalized in our division from 1991 to 2005 (mean follow-up = 10.93 ± 4.26 years) were studied. Stepwise Cox regression analysis was used to identify the influence of residual ß-cell function, ß-cell autoimmunity, HbA1c levels and other clinical and laboratory parameters in the development of microalbuminuria and retinopathy. R…

Malemedicine.medical_specialtyAdolescentendocrine system diseasesSettore MED/13 - EndocrinologiaNephropathyYoung AdultPredictive Value of TestsInsulin-Secreting CellsInternal medicineDiabetes mellitusInternal MedicinemedicineAlbuminuriaHumansDiabetic NephropathiesLongitudinal StudiesAge of OnsetChildAutoantibodiesProportional Hazards ModelsGlycated HemoglobinInpatientsType 1 diabetesDiabetic Retinopathybusiness.industryMicrocirculationMicroangiopathyType 1 diabetes microvascular Complicationsnutritional and metabolic diseasesmedicine.diseaseSurgeryDiabetes Mellitus Type 1Metabolic control analysisPredictive value of testsFemaleMicroalbuminuriaAge of onsetbusinessDiabetic AngiopathiesFollow-Up StudiesEuropean Journal of Internal Medicine
researchProduct

Optical quality of hyperopic and myopic phakic intraocular lenses

2013

Aims: To assess and compare the optical quality of the myopic and hyperopic implantable collamer lens (ICL) from its wavefront aberrations for different powers and pupil diameters. Settings and Design: Prospective study. Material and Methods: The wavefront aberrations of two myopic (−3 and −6 diopters (D)) and two hyperopic V4b ICLs (+3 and +6D) were measured in vitro . To assess and compare the optical quality of different powers of ICLs, we analyzed the root mean square (RMS) of total higher order aberrations (HOAs), trefoil, coma, tetrafoil, secondary astigmatism, and spherical aberration at 3- and 4.5-mm pupil. In addition, the point spread functions (PSFs) of each ICL evaluated were ca…

steep corneal curvatureintravitreallacrimal fossaRefractive errorvisual acuitygenetic structurespterygium surgerystandard automated perimetryComa (optics)BlindnessPhakic intraocular lenslaw.inventionsubconjunctival bevacizumab injectionCorneaLens Implantation Intraocularlcsh:Ophthalmologylawmodified deep anterior lamellar keratoplastyMitomycin CMaterials TestingAutogenous tissue graftingProspective StudiesDioptreoptical qualityshort wave automated perimetryexcimer lasernon-proliferative diabetic retinopathyMean deviationin vitroheavy silicone oilBevacizumabLens (optics)Aberrations of the eyeSpherical aberrationHyperopiaAntimicrobial effectOriginal ArticleTriamcinolone acetonidehuman trabecular meshwork cellsPhakic Intraocular Lensesmedicine.medical_specialtyImaging in glaucomadisability evaluationconventional silicone oiltriamcinoloneProsthesis DesignKeratoconusphotorefractive keratectomyOphthalmologygrowth factorsmedicineHumansmyopiamyopic implantable collamer lensshort fluctuationsWavefrontmacular edemaoptical coherence tomographyendophthalmitis agentsbusiness.industrybranch retinal vein occlusionretinal nerve fiber layerpterygium recurrencemedicine.diseaseeye diseasesOphthalmologypediatricwavefront aberrationsquality of lifelcsh:RE1-994bypass surgeryHyperopic implantable collamer lenslacrimal drainage systemsense organsbusinessIndian Journal of Ophthalmology
researchProduct

Antioxidant supplementation in diabetic retinopathy

2020

Conventional treatments for diabetic retinopathy (DR) include glycaemic control, laser photocoagulation, vitrectomy, intravitreal triamcinolone, and intravitreal antivascular endothelial growth factor agents. However, these strategies have not been proven capable of halting the progression of this disease in all cases. The mechanisms leading to DR are not fully understood, but there is a growing body of evidence showing that oxidative stress plays a pivotal role in the development of this diabetic complications. Indeed, it has been proposed that oxidative stress is the initial and maintaining event that triggers and provides feedback to the other pathophysiological pathways related to DR. T…

Antioxidantbusiness.industrymedicine.medical_treatmentGrowth factorDiabetesEnfermedad cardiovascularRetinalVitrectomyDiabetic retinopathyDiseasePharmacologymedicine.diseasemedicine.disease_causePathophysiologychemistry.chemical_compoundTratamiento médicochemistryCegueraMedicinebusinessOxidative stress
researchProduct

Intraoperative dexamethasone intravitreal implant in diabetic macular edema patients undergoing phacoemulsification: The CataDex study

2021

Purpose To assess the impact of preoperative intravitreal dexamethasone implant (DexI) on functional and anatomic outcomes in patients with diabetic macular edema (DME) who underwent phacoemulsification cataract surgery. Methods Prospective and non-comparative study conducted on consecutive DME patients undergoing cataract surgery. DexI was administered 15 days before surgery and in a pro re nata regime after surgery. Main outcome measures were mean change in central retinal thickness (CRT), central subfield thickness (CST), total macular volume (TMV), and central subfield volume (CSV) from baseline to month-12. Secondary outcome was mean change in best corrected visual acuity (BCVA). Resul…

Drug ImplantsDiabetic Retinopathygenetic structuresSettore MED/30 - Malattie Apparato Visivoreal worldGeneral Medicineeye diseasesDexamethasoneMacular EdemaOphthalmologycataractIntravitreal InjectionsphacoemulsificationDiabetes MellitusHumansProspective StudiesDexamethasone implantdiabetic macular edemaGlucocorticoidsTomography Optical Coherence
researchProduct

Fluocinolone acetonide vitreous insert for chronic diabetic macular oedema: a systematic review with meta-analysis of real-world experience

2021

AbstractWe conducted a meta-analysis of real-world studies on the 0.19 mg Fluocinolone Acetonide (FAc) intravitreal implant for chronic diabetic macular oedema (DMO), comparing these findings with the Fluocinolone Acetonide for Diabetic Macular Edema (FAME) study. The primary outcome was mean change of best corrected visual acuity (BCVA) at 24 months. Secondary outcomes were 36-month mean BCVA, mean central macular thickness (CMT) change, rates of eyes receiving supplementary intravitreal therapy, cataract surgery, intraocular pressure (IOP)-lowering drops and glaucoma surgery. Mean differences (MDs) with 95% confidence intervals (CIs) were calculated. Nine real-world studies were included.…

medicine.medical_specialtyIntraocular pressuregenetic structuresSciencemedicine.medical_treatmentAnti-Inflammatory AgentsArticleMacular Edema03 medical and health sciences0302 clinical medicineDiabetes complicationsFluocinolone acetonideOphthalmologymedicineGlaucoma surgeryHumans030212 general & internal medicineGlucocorticoidsIntraocular PressureDrug ImplantsDiabetic RetinopathyMultidisciplinarybusiness.industryQRCataract surgeryRetinal diseaseseye diseasesConfidence intervalFluocinolone AcetonideDiabetic macular oedemaMeta-analysis030221 ophthalmology & optometryMedicinesense organsImplantbusinessmedicine.drugScientific Reports
researchProduct